ClinicalTrials.Veeva

Menu

Evaluation of 3D Ultrasound in Brain Tumor Surgery (Neuro3DUS)

U

University of Ulm

Status

Enrolling

Conditions

Residual Tumor

Treatments

Device: resection with help of 3D ultrasound

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05956977
Neuro3DUS

Details and patient eligibility

About

Evaluation of impact of use of 3D ultrasound in brain tumor surgery on extend of resection. Benefit for surgery, neurological outcome, accuracy and image quality are secondary outcome parameters. Control group is a retrospective matched pair cohort.

Enrollment

90 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age above 18 suspected intra-axial lesion (metastasis or Glioma) potential gross total resection of lesion

Exclusion criteria

  • no ability for informed consent

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

90 participants in 2 patient groups

prospective arm
Experimental group
Description:
Use of 3D ultrasound intraoperative before intraoperative MRI
Treatment:
Device: resection with help of 3D ultrasound
retrospective matched pair arm
No Intervention group
Description:
no use of intraoperative ultrasound before intraoperative MRI

Trial contacts and locations

2

Loading...

Central trial contact

Christian R Wirtz, Prof. Dr. med.; Jan Coburger, apl. Prof. Dr. med.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems